RECOFOL N
Recofol N is a Bayer-originated intravenous anaesthetic, which is used by intensive care units, surgeries and clinics.
Primex Pharmaceuticals obtained Recofol N through an acquisition from Bayer in 2012. Recofol N’s active ingredient is propofol, which is the most widely used intravenous anaesthetic. Recofol N is known for its versatility, quality, speed, and lack of uncomfortable side effects such as dizziness and post-operative nausea.


Recofol EDTA
Recofol EDTA (propofol plus EDTA) is propofol with the preservative EDTA as an antimicrobial retardant, as required by the FDA and other authorities and is manufactured in EU.